Running Point Capital Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$442K Sell
3,529
-368
-9% -$46.9K 0.12% 91
2025
Q3
$522K Buy
3,897
+236
+6% +$31K 0.14% 87
2025
Q2
$498K Buy
3,661
+78
+2% +$10.3K 0.14% 82
2025
Q1
$475K Buy
3,583
+383
+12% +$48.7K 0.15% 78
2024
Q4
$362K Sell
3,200
-22
-0.7% -$2.54K 0.12% 79
2024
Q3
$367K Hold
3,222
0.14% 70
2024
Q2
$335K Sell
3,222
-35
-1% -$3.71K 0.14% 75
2024
Q1
$370K Buy
+3,257
New +$373K 0.17% 70

Other funds holding ABT

Running Point Capital Advisors's ABT Position: Q4 2025 in Review

Running Point Capital Advisors reduced its Abbott (ABT) stake by 9.4% in Q4 2025, selling an estimated $46.9K and leaving 3,529 shares worth $442K. The position accounts for 0.12% of the portfolio, ranked #91.

Running Point Capital Advisors first reported a position in ABT in Q1 2024 and has held it in 8 quarters since. The position peaked at $522K in Q3 2025. 3,276 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • Running Point Capital Advisors held 3,529 shares of Abbott worth $442K as of Q4 2025.
  • Running Point Capital Advisors sold 368 Abbott shares in Q4 2025, an estimated $46.9K.
  • Abbott made up 0.12% of Running Point Capital Advisors's portfolio in Q4 2025, its #91 holding.
  • Running Point Capital Advisors first reported a position in Abbott in Q1 2024 and has held it in 8 quarters since.
  • Running Point Capital Advisors's Abbott position peaked at $522K in Q3 2025.
  • 3,276 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Running Point Capital Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.